These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6282541)

  • 21. Dimensions of publicness and performance in substance abuse treatment organizations.
    Heinrich CJ; Fournier E
    J Policy Anal Manage; 2004; 23(1):49-70. PubMed ID: 14976993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Managed care in the public sector: the federal role.
    Goplerud E
    Behav Healthc Tomorrow; 1996 Apr; 5(2):71-3. PubMed ID: 10157579
    [No Abstract]   [Full Text] [Related]  

  • 23. Restructuring public mental health and substance abuse service systems.
    Godbole A; Temkin T; Cradock C
    J Health Care Finance; 1998; 24(3):16-26. PubMed ID: 9502053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. State mandates for mental health, alcohol, and substance abuse benefits: implications for HMOs.
    Levin BL
    GHAA J; 1988; 9(2):48-69. PubMed ID: 10318180
    [No Abstract]   [Full Text] [Related]  

  • 25. Managed care, networks and trends in hospital care for mental health and substance abuse treatment in Massachusetts: 1994-1999.
    Fleming E; Lien H; Ma CT; McGuire TG
    J Ment Health Policy Econ; 2003 Mar; 6(1):3-12. PubMed ID: 14578543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology and health service resource allocation policy for alcohol, drug abuse, and mental disorders.
    Regier DA; Shapiro S; Kessler LG; Taube CA
    Public Health Rep; 1984; 99(5):483-92. PubMed ID: 6435161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship between employer health insurance characteristics and the provision of employee assistance programs.
    Zarkin GA; Garfinkel SA
    Inquiry; 1994; 31(1):102-14. PubMed ID: 8168905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Economic aspects of clinical decision making: evaluating clinical programs.
    Hepler CD
    Am J Hosp Pharm; 1988 Mar; 45(3):554-60. PubMed ID: 3369458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative analysis of state requirements for the training of substance abuse and mental health counselors.
    Kerwin ME; Walker-Smith K; Kirby KC
    J Subst Abuse Treat; 2006 Apr; 30(3):173-81. PubMed ID: 16616160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A profile of the substance abuse treatment industry: organization, costs, and treatment completion.
    Woodward AM; Raskin IE; Blacklow B
    Subst Use Misuse; 2008; 43(5):647-79. PubMed ID: 18393082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alcohol, Drug Abuse, and Mental Health Services block grant state waiver guidelines; construction or rehabilitation of substance abuse facilities--ADAMHA. Notice.
    Fed Regist; 1989 Jun; 54(105):23699-700. PubMed ID: 10318231
    [No Abstract]   [Full Text] [Related]  

  • 32. An analysis of the effects of organization and financing on the utilization and costs of public mental health services in san diego county.
    Gilmer T
    J Ment Health Policy Econ; 2007 Sep; 10(3):123-32. PubMed ID: 17890829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. America's mental health: goals and programs of the National Institute of Mental Health.
    Pardes H
    Urban Health; 1981 Nov; 10(9):30-3. PubMed ID: 10313916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Personal Responsibility and Work Opportunity Reconciliation Act of 1996 (PRWORA); interpretation of "federal public benefit"--HHS. Notice with comment period.
    Fed Regist; 1998 Aug; 63(149):41658-61. PubMed ID: 10181721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fiscal year (FY) 1999 funding opportunities. Substance Abuse and Mental Health Services Administration, HHS. Notice of funding availability.
    Fed Regist; 1999 Mar; 64(44):11027-31. PubMed ID: 10557624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expanding the role of health services research as a tool to reduce the public health burden of alcohol use disorders.
    Delany PJ; Shields JJ; Willenbring ML; Huebner RB
    Subst Use Misuse; 2008; 43(12-13):1729-46. PubMed ID: 19016162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using RE-AIM metrics to evaluate diabetes self-management support interventions.
    Glasgow RE; Nelson CC; Strycker LA; King DK
    Am J Prev Med; 2006 Jan; 30(1):67-73. PubMed ID: 16414426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implementing and using quality measures for children's health care: perspectives on the state of the practice.
    Shaller D
    Pediatrics; 2004 Jan; 113(1 Pt 2):217-27. PubMed ID: 14702504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perspectives on policy research.
    Eichhorn RL; Wysong JA
    Health Serv Res; 1972; 7(4):272-5. PubMed ID: 4347098
    [No Abstract]   [Full Text] [Related]  

  • 40. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.